针对Shp2作为神经退行性疾病的治疗策略
Jiao Pang1,2,3, Changqian Cen1, Yuan Tian4
1Department of Forensic Pathology, School of Forensic Medicine, China Medical University, Shenyang, Liaoning Province, PR China.
Translational psychiatry
|January 10, 2025
概括
氨酸酸酶Shp2在神经退行性疾病 (NDs) 中起着双重作用,既起保护作用,又起损害促进作用. 了解Shp2的复杂调节是开发针对ND的向治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 神经退行性疾病 (NDs) 的发病率正在上升,目前的治疗方法在很大程度上是缓解性.
- 缺乏对ND的有效治疗药物,需要更深入地了解疾病机制.
- 氨酸酸酶Shp2 (Src同质性2域含酸酶2),一种氨酸酸酶,已在癌症中进行研究,但其在神经系统中的作用尚未得到充分研究.
研究的目的:
- 审查神经退行性疾病中Shp2调节的分子机制.
- 阐明Shp2在各种ND相关的致病因子中的多方面的作用.
- 在开发新型ND疗法时,提供针对Shp2的证据.
主要方法:
- 关于神经系统中Shp2功能的现有研究的文献综述.
- 对Shp2参与神经退行相关的信号通路的分析.
- 检查Shp2与NDs的关键病理因素的相互作用.
主要成果:
- Shp2在ND中表现出独特的双向调节作用,既作为潜在的检查点,又作为病变的促进者.
- Shp2与主要的ND病原性因素密切相关,包括氧化应激,线粒体功能障碍,兴奋毒性,神经炎症,亡和自.
- Shp2 作为一个复杂的信号通路网络中的核心组件,调解反和交叉通话.
结论:
- Shp2复杂的双重作用凸显了它在神经退行性疾病的发病过程中的重要性.
- 向Shp2为开发用于NDs的新型分子向药物提供了一个有希望的战略.
- 对Shp2调节的进一步研究对于推进ND治疗至关重要.
相关概念视频
01:15Parkinson's Disease: Overview
472
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
472
01:22Alzheimer's Disease: Treatment
161
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
161
01:24Parkinson's Disease: Treatment
215
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
215
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K